ReviewPharmacology & therapeutics2020

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.

James Jiqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.